본문으로 건너뛰기
← 뒤로

Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study.

World journal of clinical cases 2021 Vol.9(32) p. 9722-9730

D'Orazio B, Geraci G, Famà F, Terranova G, Di Vita G

관련 도메인

📝 환자 설명용 한 줄

[BACKGROUND] Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-r

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 연구 설계 case-control

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA D'Orazio B, Geraci G, et al. (2021). Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study.. World journal of clinical cases, 9(32), 9722-9730. https://doi.org/10.12998/wjcc.v9.i32.9722
MLA D'Orazio B, et al.. "Botulinum toxin associated with fissurectomy and anoplasty for hypertonic chronic anal fissure: A case-control study.." World journal of clinical cases, vol. 9, no. 32, 2021, pp. 9722-9730.
PMID 34877311

Abstract

[BACKGROUND] Lateral internal sphincterotomy is still the approach of choice for the treatment of chronic anal fissure (CAF) with internal anal sphincter (IAS) hypertonia, but it is burdened by high-risk postoperative faecal incontinence (FI). Sphincter saving procedures have recently been reconsidered as treatments to overcome this risk. The most employed procedure is fissurectomy with anoplasty, eventually associated with pharmacological sphincterotomy.

[AIM] To evaluate whether fissurectomy and anoplasty with botulinum toxin injection improves the results of fissurectomy and anoplasty alone.

[METHODS] We conducted a case-control study involving 30 male patients affected by CAF with hypertonic IAS who underwent fissurectomy and anoplasty with V-Y cutaneous flap advancement. The patients were divided into two groups: Those in group I underwent surgery alone, and those in group II underwent surgery and a botulinum toxin injection directly into the IAS. They were followed up for at least 2 years. The goals were to achieve complete healing of the patient and to assess the FI and recurrence rate along with manometry parameters.

[RESULTS] The intensity and duration of post-defecatory pain decreased significantly in both groups of patients starting with the first defecation, and this reduction was higher in group II. Forty days after surgery, we achieved complete wound healing in all the patients in group II but only in 80% of the patients in group I ( < 0.032). We recorded 2 cases of recurrence, one in each group, and both healed with conservative therapy. We recorded one temporary and low-grade postoperative case of "" FI. Manometry parameters reverted to the normal range earlier for group II patients.

[CONCLUSION] The injection of botulinum toxin A in association with fissurectomy and anoplasty with a V-Y advancement flap improves the results of surgery alone in patients affected by CAF with IAS hypertonia.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 4
시술 flap 피판재건술 dict 2

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

같은 제1저자의 인용 많은 논문 (1)

관련 논문